Search our database by keyword

Examples

Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 329 out of 329 for Keap1

Category restricted to Publication

<< First < Previous | Next > Last >>

0.033s

Type

Details

Score

Publication

26300493 | J:225964

First Author:	Duru N
Year:	2015
Journal:	Cancer Lett
Title:	NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts.
Volume:	369
Issue:	1
Pages:	184-91

•

Publication

28542357 | J:248523

First Author:	Gonzalez-Donquiles C
Year:	2017
Journal:	PLoS One
Title:	The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review.
Volume:	12
Issue:	5
Pages:	e0177549

•

Publication

30323285 | J:267115

First Author:	Bollong MJ
Year:	2018
Journal:	Nature
Title:	A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling.
Volume:	562
Issue:	7728
Pages:	600-604

•

Publication

31781322 | J:290496

First Author:	Hu X
Year:	2019
Journal:	Oxid Med Cell Longev
Title:	miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice.
Volume:	2019

Pages:	1512326

•

Publication

32251645 | J:292730

First Author:	Ren X
Year:	2020
Journal:	Exp Cell Res
Title:	TRIM16 protects from OGD/R-induced oxidative stress in cultured hippocampal neurons by enhancing Nrf2/ARE antioxidant signaling via downregulation of Keap1.
Volume:	391
Issue:	1
Pages:	111988

•

Publication

32636316 | J:296314

First Author:	Hayashi M
Year:	2020
Journal:	Cancer Res
Title:	Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors.
Volume:	80
Issue:	16
Pages:	3331-3344

•

Publication

33672789 | J:305742

First Author:	Hamada S
Year:	2021
Journal:	Int J Mol Sci
Title:	Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition.
Volume:	22
Issue:	4

•

Publication

33707235 | J:307161

First Author:	Foggetti G
Year:	2021
Journal:	Cancer Discov
Title:	Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.

•

Publication

23587556 | J:315506

First Author:	Hayashi R
Year:	2013
Journal:	Free Radic Biol Med
Title:	The role of the Nrf2-mediated defense system in corneal epithelial wound healing.
Volume:	61

Pages:	333-42

•

Publication

22367278 | J:318947

First Author:	Okada K
Year:	2012
Journal:	J Gastroenterol
Title:	Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.
Volume:	47
Issue:	8
Pages:	924-35

•

Publication

36657732 | J:344588

First Author:	Wan Y
Year:	2023
Journal:	Free Radic Biol Med
Title:	Baicalein limits osteoarthritis development by inhibiting chondrocyte ferroptosis.
Volume:	196

Pages:	108-120

•

Publication

36230622 | J:330142

First Author:	Hirose W
Year:	2022
Journal:	Cancers (Basel)
Title:	The KEAP1-NRF2 System and Esophageal Cancer.
Volume:	14
Issue:	19

•

Publication

37729796 | J:342403

First Author:	Liu B
Year:	2023
Journal:	Int Immunopharmacol
Title:	Tripartite motif containing 59 mediates protective anti-oxidative effects in intestinal injury through Nrf2 signaling.
Volume:	124
Issue:	Pt B
Pages:	110896

•

Publication

37729426 | J:343793

First Author:	Mukhopadhyay S
Year:	2023
Journal:	Cancer Res
Title:	Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
Volume:	83
Issue:	24
Pages:	4095-4111

•

Publication

30897380 | J:290394

First Author:	Zhu Y
Year:	2019
Journal:	Atherosclerosis
Title:	Z-Ligustilide protects vascular endothelial cells from oxidative stress and rescues high fat diet-induced atherosclerosis by activating multiple NRF2 downstream genes.
Volume:	284

Pages:	110-120

•

Publication

33395605 | J:303126

First Author:	Liao K
Year:	2021
Journal:	Biomed Pharmacother
Title:	Sinomenine protects bone from destruction to ameliorate arthritis via activating p62^{Thr269/Ser272}-Keap1-Nrf2 feedback loop.
Volume:	135

Pages:	111195

•

Publication

33628382 | J:310643

First Author:	Lou Y
Year:	2021
Journal:	Oxid Med Cell Longev
Title:	Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus.
Volume:	2021

Pages:	7866720

•

Publication

29233793 | J:259623

First Author:	Su X
Year:	2018
Journal:	Free Radic Biol Med
Title:	Licochalcone A activates Keap1-Nrf2 signaling to suppress arthritis via phosphorylation of p62 at serine 349.
Volume:	115

Pages:	471-483

•

Publication

22919281 | J:349083

First Author:	Kombairaju P
Year:	2012
Journal:	J Carcinog
Title:	Prolonged sulforaphane treatment does not enhance tumorigenesis in oncogenic K-ras and xenograft mouse models of lung cancer.
Volume:	11

Pages:	8

•

Publication

32619021 | J:299778

First Author:	Bowman BM
Year:	2020
Journal:	J Pathol
Title:	A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue.
Volume:	252
Issue:	2
Pages:	125-137

•

Publication

25920363 | J:315355

First Author:	Wang J
Year:	2015
Journal:	Free Radic Biol Med
Title:	Sigma 1 receptor regulates the oxidative stress response in primary retinal Müller glial cells via NRF2 signaling and system xc(-), the Na(+)-independent glutamate-cystine exchanger.
Volume:	86

Pages:	25-36

•

Publication

29634312 | J:266070

First Author:	Zhang J
Year:	2018
Journal:	Am J Physiol Endocrinol Metab
Title:	HDAC3 inhibition in diabetic mice may activate Nrf2 preventing diabetes-induced liver damage and FGF21 synthesis and secretion leading to aortic protection.
Volume:	315
Issue:	2
Pages:	E150-E162

•

Publication

34233258 | J:313746

First Author:	Hou K
Year:	2021
Journal:	EBioMedicine
Title:	Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin.
Volume:	69

Pages:	103456

•

Publication

39243573 | J:359342

First Author:	Sanz-Alcázar A
Year:	2024
Journal:	Redox Biol
Title:	Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1/AMPK, KEAP1, and GSK3β in the impairment of the NRF2 response.
Volume:	76

Pages:	103339

•

Publication

18164232 | J:138913

First Author:	Osburn WO
Year:	2008
Journal:	Mutat Res
Title:	Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults.
Volume:	659
Issue:	1-2
Pages:	31-9

•

Publication

30114225 | J:356874

First Author:	Rooney J
Year:	2018
Journal:	PLoS One
Title:	Activation of Nrf2 in the liver is associated with stress resistance mediated by suppression of the growth hormone-regulated STAT5b transcription factor.
Volume:	13
Issue:	8
Pages:	e0200004

•

Publication

28482326 | J:308285

First Author:	Shanmugam G
Year:	2017
Journal:	Redox Biol
Title:	Constitutive activation of Nrf2 induces a stable reductive state in the mouse myocardium.
Volume:	12

Pages:	937-945

•

Publication

31885821 | J:292418

First Author:	Cong P
Year:	2019
Journal:	Oxid Med Cell Longev
Title:	CD28 Deficiency Ameliorates Thoracic Blast Exposure-Induced Oxidative Stress and Apoptosis in the Brain through the PI3K/Nrf2/Keap1 Signaling Pathway.
Volume:	2019

Pages:	8460290

•

Publication

32105670 | J:353988

First Author:	He F
Year:	2020
Journal:	J Hepatol
Title:	NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly.
Volume:	72
Issue:	6
Pages:	1182-1195

•

Questions? Comments? Click here!

MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Your name:
Your email address:
Subject:
Message:	---- Current page: ---- /mousemine/keywordSearchResults.do?facet_Category=Publication&searchOffset=300&searchTerm=Keap1

MouseMine

Search our database by keyword

Examples

Search results 301 to 329 out of 329 for Keap1

Category restricted to Publication

Categories